Country: United States
Language: English
Source: NLM (National Library of Medicine)
prednisolone acetate (UNII: 8B2807733D) (prednisolone - UNII:9PHQ9Y1OLM)
Preferred Pharmaceuticals, Inc
prednisolone acetate
prednisolone acetate 1.2 mg in 1 mL
PRESCRIPTION DRUG
New Drug Application
PRED MILD- PREDNISOLONE ACETATE SUSPENSION/ DROPS PREFERRED PHARMACEUTICALS, INC ---------- PRED MILD (PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION, USP) 0.12% S TERILE DESCRIPTION PRED MILD (prednisolone acetate ophthalmic suspension, USP) 0.12% is a sterile, topical anti- inflammatory agent for ophthalmic use. Its chemical name is 11ß,17, 21-Trihydroxypregna-1,4-diene-3, 20-dione 21-acetate and it has the following structure: STRUCTURAL FORMULA: prednisolone acetate ACTIVE: prednisolone acetate (microfine suspension) 0.12%. INACTIVES: benzalkonium chloride as preservative; boric acid; edetate disodium; hypromellose; polysorbate 80; purified water; sodium bisulfite; sodium chloride; and sodium citrate. The pH during its shelf life ranges from 5.0 - 6.0. CLINICAL PHARMACOLOGY Prednisolone acetate is a glucocorticoid that, on the basis of weight, has 3 to 5 times the anti- inflammatory potency of hydrocortisone. Glucocorticoids inhibit the edema, fibrin deposition, capillary dilation, and phagocytic migration of the acute inflammatory response, as well as capillary proliferation, deposition of collagen, and scar formation. INDICATIONS AND USAGE PRED MILD is indicated for the treatment of mild to moderate noninfectious allergic and inflammatory disorders of the lid, conjunctiva, cornea, and sclera (including chemical and thermal burns). CONTRAINDICATIONS PRED MILD suspension is contraindicated in acute untreated purulent ocular infections, in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), ® ® ® ® vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. PRED MILD suspension is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids. WARNINGS Prolonged use of corticosteroids may result in posterior subcapsular cataract formation and may increase intraocular pressure in susceptible individuals, Read the complete document